Sign in
Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: A pilot study
Conference proceeding

Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: A pilot study

Mauricio LYNN, Igor JEROKHIMOV, Dory JEWELEWICZ, Charles POPKIN, Edward W JOHNSON, Qammar N RASHID, Margareth BROWN, Uri MARTINOWITZ and Stephen M COHN
The Journal of trauma, injury, infection, and critical care, Vol.52(4), pp.703-707
2002
PMID: 11956387

Abstract

Biological and medical sciences Medical sciences Blood. Blood coagulation. Reticuloendothelial system Pharmacology. Drug treatments

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.75 Blood Clotting
1.75.324 Transfusion
Web Of Science research areas
Critical Care Medicine
Surgery
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details